0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global OTC Anti-Infective Medicine Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-0L12953
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global OTC Anti Infective Medicine Market Research Report 2022
BUY CHAPTERS

Global OTC Anti-Infective Medicine Market Research Report 2025

Code: QYRE-Auto-0L12953
Report
February 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

OTC Anti-Infective Medicine Market Size

The global market for OTC Anti-Infective Medicine was valued at US$ 14650 million in the year 2024 and is projected to reach a revised size of US$ 18450 million by 2031, growing at a CAGR of 3.4% during the forecast period.

OTC Anti-Infective Medicine Market

OTC Anti-Infective Medicine Market

Anti-infectives are medicines that work to prevent or treat infections, they include antibacterials, antivirals, antifungals and antiparasitic medications.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for OTC Anti-Infective Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Anti-Infective Medicine.
The OTC Anti-Infective Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global OTC Anti-Infective Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Anti-Infective Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of OTC Anti-Infective Medicine Market Report

Report Metric Details
Report Name OTC Anti-Infective Medicine Market
Accounted market size in year US$ 14650 million
Forecasted market size in 2031 US$ 18450 million
CAGR 3.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GlaxoSmithKline, Merck, Pfizer, Novartis, Abbott, Sanofi, Bristol-Myers Squibb, Roche
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of OTC Anti-Infective Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is OTC Anti-Infective Medicine Market growing?

Ans: The OTC Anti-Infective Medicine Market witnessing a CAGR of 3.4% during the forecast period 2025-2031.

What is the OTC Anti-Infective Medicine Market size in 2031?

Ans: The OTC Anti-Infective Medicine Market size in 2031 will be US$ 18450 million.

Who are the main players in the OTC Anti-Infective Medicine Market report?

Ans: The main players in the OTC Anti-Infective Medicine Market are GlaxoSmithKline, Merck, Pfizer, Novartis, Abbott, Sanofi, Bristol-Myers Squibb, Roche

What are the Application segmentation covered in the OTC Anti-Infective Medicine Market report?

Ans: The Applications covered in the OTC Anti-Infective Medicine Market report are Hospital, Retail Pharmacy

What are the Type segmentation covered in the OTC Anti-Infective Medicine Market report?

Ans: The Types covered in the OTC Anti-Infective Medicine Market report are Antibacterials Medicine, Antivirals Medicine, Antifungals Medicine, Antiparasitic Medicine

Recommended Reports

OTC & Anti-Infectives

Antifungal & Antimicrobial

Vaccine & Viral Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Anti-Infective Medicine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antibacterials Medicine
1.2.3 Antivirals Medicine
1.2.4 Antifungals Medicine
1.2.5 Antiparasitic Medicine
1.3 Market by Application
1.3.1 Global OTC Anti-Infective Medicine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global OTC Anti-Infective Medicine Market Perspective (2020-2031)
2.2 Global OTC Anti-Infective Medicine Growth Trends by Region
2.2.1 Global OTC Anti-Infective Medicine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 OTC Anti-Infective Medicine Historic Market Size by Region (2020-2025)
2.2.3 OTC Anti-Infective Medicine Forecasted Market Size by Region (2026-2031)
2.3 OTC Anti-Infective Medicine Market Dynamics
2.3.1 OTC Anti-Infective Medicine Industry Trends
2.3.2 OTC Anti-Infective Medicine Market Drivers
2.3.3 OTC Anti-Infective Medicine Market Challenges
2.3.4 OTC Anti-Infective Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top OTC Anti-Infective Medicine Players by Revenue
3.1.1 Global Top OTC Anti-Infective Medicine Players by Revenue (2020-2025)
3.1.2 Global OTC Anti-Infective Medicine Revenue Market Share by Players (2020-2025)
3.2 Global OTC Anti-Infective Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by OTC Anti-Infective Medicine Revenue
3.4 Global OTC Anti-Infective Medicine Market Concentration Ratio
3.4.1 Global OTC Anti-Infective Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Anti-Infective Medicine Revenue in 2024
3.5 Global Key Players of OTC Anti-Infective Medicine Head office and Area Served
3.6 Global Key Players of OTC Anti-Infective Medicine, Product and Application
3.7 Global Key Players of OTC Anti-Infective Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Anti-Infective Medicine Breakdown Data by Type
4.1 Global OTC Anti-Infective Medicine Historic Market Size by Type (2020-2025)
4.2 Global OTC Anti-Infective Medicine Forecasted Market Size by Type (2026-2031)
5 OTC Anti-Infective Medicine Breakdown Data by Application
5.1 Global OTC Anti-Infective Medicine Historic Market Size by Application (2020-2025)
5.2 Global OTC Anti-Infective Medicine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America OTC Anti-Infective Medicine Market Size (2020-2031)
6.2 North America OTC Anti-Infective Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America OTC Anti-Infective Medicine Market Size by Country (2020-2025)
6.4 North America OTC Anti-Infective Medicine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe OTC Anti-Infective Medicine Market Size (2020-2031)
7.2 Europe OTC Anti-Infective Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe OTC Anti-Infective Medicine Market Size by Country (2020-2025)
7.4 Europe OTC Anti-Infective Medicine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OTC Anti-Infective Medicine Market Size (2020-2031)
8.2 Asia-Pacific OTC Anti-Infective Medicine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific OTC Anti-Infective Medicine Market Size by Region (2020-2025)
8.4 Asia-Pacific OTC Anti-Infective Medicine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America OTC Anti-Infective Medicine Market Size (2020-2031)
9.2 Latin America OTC Anti-Infective Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America OTC Anti-Infective Medicine Market Size by Country (2020-2025)
9.4 Latin America OTC Anti-Infective Medicine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OTC Anti-Infective Medicine Market Size (2020-2031)
10.2 Middle East & Africa OTC Anti-Infective Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa OTC Anti-Infective Medicine Market Size by Country (2020-2025)
10.4 Middle East & Africa OTC Anti-Infective Medicine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline OTC Anti-Infective Medicine Introduction
11.1.4 GlaxoSmithKline Revenue in OTC Anti-Infective Medicine Business (2020-2025)
11.1.5 GlaxoSmithKline Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck OTC Anti-Infective Medicine Introduction
11.2.4 Merck Revenue in OTC Anti-Infective Medicine Business (2020-2025)
11.2.5 Merck Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer OTC Anti-Infective Medicine Introduction
11.3.4 Pfizer Revenue in OTC Anti-Infective Medicine Business (2020-2025)
11.3.5 Pfizer Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis OTC Anti-Infective Medicine Introduction
11.4.4 Novartis Revenue in OTC Anti-Infective Medicine Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott OTC Anti-Infective Medicine Introduction
11.5.4 Abbott Revenue in OTC Anti-Infective Medicine Business (2020-2025)
11.5.5 Abbott Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi OTC Anti-Infective Medicine Introduction
11.6.4 Sanofi Revenue in OTC Anti-Infective Medicine Business (2020-2025)
11.6.5 Sanofi Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb OTC Anti-Infective Medicine Introduction
11.7.4 Bristol-Myers Squibb Revenue in OTC Anti-Infective Medicine Business (2020-2025)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche OTC Anti-Infective Medicine Introduction
11.8.4 Roche Revenue in OTC Anti-Infective Medicine Business (2020-2025)
11.8.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global OTC Anti-Infective Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Antibacterials Medicine
 Table 3. Key Players of Antivirals Medicine
 Table 4. Key Players of Antifungals Medicine
 Table 5. Key Players of Antiparasitic Medicine
 Table 6. Global OTC Anti-Infective Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global OTC Anti-Infective Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global OTC Anti-Infective Medicine Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global OTC Anti-Infective Medicine Market Share by Region (2020-2025)
 Table 10. Global OTC Anti-Infective Medicine Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global OTC Anti-Infective Medicine Market Share by Region (2026-2031)
 Table 12. OTC Anti-Infective Medicine Market Trends
 Table 13. OTC Anti-Infective Medicine Market Drivers
 Table 14. OTC Anti-Infective Medicine Market Challenges
 Table 15. OTC Anti-Infective Medicine Market Restraints
 Table 16. Global OTC Anti-Infective Medicine Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global OTC Anti-Infective Medicine Market Share by Players (2020-2025)
 Table 18. Global Top OTC Anti-Infective Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Medicine as of 2024)
 Table 19. Ranking of Global Top OTC Anti-Infective Medicine Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by OTC Anti-Infective Medicine Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of OTC Anti-Infective Medicine, Headquarters and Area Served
 Table 22. Global Key Players of OTC Anti-Infective Medicine, Product and Application
 Table 23. Global Key Players of OTC Anti-Infective Medicine, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global OTC Anti-Infective Medicine Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global OTC Anti-Infective Medicine Revenue Market Share by Type (2020-2025)
 Table 27. Global OTC Anti-Infective Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global OTC Anti-Infective Medicine Revenue Market Share by Type (2026-2031)
 Table 29. Global OTC Anti-Infective Medicine Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global OTC Anti-Infective Medicine Revenue Market Share by Application (2020-2025)
 Table 31. Global OTC Anti-Infective Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global OTC Anti-Infective Medicine Revenue Market Share by Application (2026-2031)
 Table 33. North America OTC Anti-Infective Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America OTC Anti-Infective Medicine Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America OTC Anti-Infective Medicine Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe OTC Anti-Infective Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe OTC Anti-Infective Medicine Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe OTC Anti-Infective Medicine Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific OTC Anti-Infective Medicine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific OTC Anti-Infective Medicine Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific OTC Anti-Infective Medicine Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America OTC Anti-Infective Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America OTC Anti-Infective Medicine Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America OTC Anti-Infective Medicine Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa OTC Anti-Infective Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa OTC Anti-Infective Medicine Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa OTC Anti-Infective Medicine Market Size by Country (2026-2031) & (US$ Million)
 Table 48. GlaxoSmithKline Company Details
 Table 49. GlaxoSmithKline Business Overview
 Table 50. GlaxoSmithKline OTC Anti-Infective Medicine Product
 Table 51. GlaxoSmithKline Revenue in OTC Anti-Infective Medicine Business (2020-2025) & (US$ Million)
 Table 52. GlaxoSmithKline Recent Development
 Table 53. Merck Company Details
 Table 54. Merck Business Overview
 Table 55. Merck OTC Anti-Infective Medicine Product
 Table 56. Merck Revenue in OTC Anti-Infective Medicine Business (2020-2025) & (US$ Million)
 Table 57. Merck Recent Development
 Table 58. Pfizer Company Details
 Table 59. Pfizer Business Overview
 Table 60. Pfizer OTC Anti-Infective Medicine Product
 Table 61. Pfizer Revenue in OTC Anti-Infective Medicine Business (2020-2025) & (US$ Million)
 Table 62. Pfizer Recent Development
 Table 63. Novartis Company Details
 Table 64. Novartis Business Overview
 Table 65. Novartis OTC Anti-Infective Medicine Product
 Table 66. Novartis Revenue in OTC Anti-Infective Medicine Business (2020-2025) & (US$ Million)
 Table 67. Novartis Recent Development
 Table 68. Abbott Company Details
 Table 69. Abbott Business Overview
 Table 70. Abbott OTC Anti-Infective Medicine Product
 Table 71. Abbott Revenue in OTC Anti-Infective Medicine Business (2020-2025) & (US$ Million)
 Table 72. Abbott Recent Development
 Table 73. Sanofi Company Details
 Table 74. Sanofi Business Overview
 Table 75. Sanofi OTC Anti-Infective Medicine Product
 Table 76. Sanofi Revenue in OTC Anti-Infective Medicine Business (2020-2025) & (US$ Million)
 Table 77. Sanofi Recent Development
 Table 78. Bristol-Myers Squibb Company Details
 Table 79. Bristol-Myers Squibb Business Overview
 Table 80. Bristol-Myers Squibb OTC Anti-Infective Medicine Product
 Table 81. Bristol-Myers Squibb Revenue in OTC Anti-Infective Medicine Business (2020-2025) & (US$ Million)
 Table 82. Bristol-Myers Squibb Recent Development
 Table 83. Roche Company Details
 Table 84. Roche Business Overview
 Table 85. Roche OTC Anti-Infective Medicine Product
 Table 86. Roche Revenue in OTC Anti-Infective Medicine Business (2020-2025) & (US$ Million)
 Table 87. Roche Recent Development
 Table 88. Research Programs/Design for This Report
 Table 89. Key Data Information from Secondary Sources
 Table 90. Key Data Information from Primary Sources
 Table 91. Authors List of This Report


List of Figures
 Figure 1. OTC Anti-Infective Medicine Picture
 Figure 2. Global OTC Anti-Infective Medicine Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global OTC Anti-Infective Medicine Market Share by Type: 2024 VS 2031
 Figure 4. Antibacterials Medicine Features
 Figure 5. Antivirals Medicine Features
 Figure 6. Antifungals Medicine Features
 Figure 7. Antiparasitic Medicine Features
 Figure 8. Global OTC Anti-Infective Medicine Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global OTC Anti-Infective Medicine Market Share by Application: 2024 VS 2031
 Figure 10. Hospital Case Studies
 Figure 11. Retail Pharmacy Case Studies
 Figure 12. OTC Anti-Infective Medicine Report Years Considered
 Figure 13. Global OTC Anti-Infective Medicine Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global OTC Anti-Infective Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global OTC Anti-Infective Medicine Market Share by Region: 2024 VS 2031
 Figure 16. Global OTC Anti-Infective Medicine Market Share by Players in 2024
 Figure 17. Global Top OTC Anti-Infective Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Medicine as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by OTC Anti-Infective Medicine Revenue in 2024
 Figure 19. North America OTC Anti-Infective Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America OTC Anti-Infective Medicine Market Share by Country (2020-2031)
 Figure 21. United States OTC Anti-Infective Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada OTC Anti-Infective Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe OTC Anti-Infective Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe OTC Anti-Infective Medicine Market Share by Country (2020-2031)
 Figure 25. Germany OTC Anti-Infective Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France OTC Anti-Infective Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. OTC Anti-Infective Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy OTC Anti-Infective Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia OTC Anti-Infective Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries OTC Anti-Infective Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific OTC Anti-Infective Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific OTC Anti-Infective Medicine Market Share by Region (2020-2031)
 Figure 33. China OTC Anti-Infective Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan OTC Anti-Infective Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea OTC Anti-Infective Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia OTC Anti-Infective Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India OTC Anti-Infective Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia OTC Anti-Infective Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America OTC Anti-Infective Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America OTC Anti-Infective Medicine Market Share by Country (2020-2031)
 Figure 41. Mexico OTC Anti-Infective Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil OTC Anti-Infective Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa OTC Anti-Infective Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa OTC Anti-Infective Medicine Market Share by Country (2020-2031)
 Figure 45. Turkey OTC Anti-Infective Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia OTC Anti-Infective Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE OTC Anti-Infective Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. GlaxoSmithKline Revenue Growth Rate in OTC Anti-Infective Medicine Business (2020-2025)
 Figure 49. Merck Revenue Growth Rate in OTC Anti-Infective Medicine Business (2020-2025)
 Figure 50. Pfizer Revenue Growth Rate in OTC Anti-Infective Medicine Business (2020-2025)
 Figure 51. Novartis Revenue Growth Rate in OTC Anti-Infective Medicine Business (2020-2025)
 Figure 52. Abbott Revenue Growth Rate in OTC Anti-Infective Medicine Business (2020-2025)
 Figure 53. Sanofi Revenue Growth Rate in OTC Anti-Infective Medicine Business (2020-2025)
 Figure 54. Bristol-Myers Squibb Revenue Growth Rate in OTC Anti-Infective Medicine Business (2020-2025)
 Figure 55. Roche Revenue Growth Rate in OTC Anti-Infective Medicine Business (2020-2025)
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart